DD232489A1 - Verfahren zur herstellung von s(-)-3-(3-acetyl-4-(3-tert. butylamino-2-hydroxypropoxy)-phenyl)-1,1-diaethylharnstoff - Google Patents

Verfahren zur herstellung von s(-)-3-(3-acetyl-4-(3-tert. butylamino-2-hydroxypropoxy)-phenyl)-1,1-diaethylharnstoff Download PDF

Info

Publication number
DD232489A1
DD232489A1 DD85274250A DD27425085A DD232489A1 DD 232489 A1 DD232489 A1 DD 232489A1 DD 85274250 A DD85274250 A DD 85274250A DD 27425085 A DD27425085 A DD 27425085A DD 232489 A1 DD232489 A1 DD 232489A1
Authority
DD
German Democratic Republic
Prior art keywords
acid
celiprolol
pharmaceutically acceptable
formula
salt
Prior art date
Application number
DD85274250A
Other languages
German (de)
English (en)
Inventor
Zoelss
Gratz
Schloegl
Hofer
Gordon
Original Assignee
Chemie Linz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemie Linz Ag filed Critical Chemie Linz Ag
Publication of DD232489A1 publication Critical patent/DD232489A1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/32—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
    • C07C275/34—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms having nitrogen atoms of urea groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Epoxy Compounds (AREA)
DD85274250A 1984-03-21 1985-03-19 Verfahren zur herstellung von s(-)-3-(3-acetyl-4-(3-tert. butylamino-2-hydroxypropoxy)-phenyl)-1,1-diaethylharnstoff DD232489A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843410380 DE3410380A1 (de) 1984-03-21 1984-03-21 S(-)-celiprolol, dessen pharmazeutisch vertraegliche salze, verfahren zu dessen herstellung, verwendung in der therapie und pharmazeutische zubereitungen

Publications (1)

Publication Number Publication Date
DD232489A1 true DD232489A1 (de) 1986-01-29

Family

ID=6231193

Family Applications (2)

Application Number Title Priority Date Filing Date
DD85274249A DD234860A1 (de) 1984-03-21 1985-03-19 Verfahren zur herstellung von s(-)-3-/3-acetyl-4-(3-tert-butylamino-2-hydroxypropoxy-phenyl/1,1-diaethylharnstoff
DD85274250A DD232489A1 (de) 1984-03-21 1985-03-19 Verfahren zur herstellung von s(-)-3-(3-acetyl-4-(3-tert. butylamino-2-hydroxypropoxy)-phenyl)-1,1-diaethylharnstoff

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DD85274249A DD234860A1 (de) 1984-03-21 1985-03-19 Verfahren zur herstellung von s(-)-3-/3-acetyl-4-(3-tert-butylamino-2-hydroxypropoxy-phenyl/1,1-diaethylharnstoff

Country Status (21)

Country Link
EP (1) EP0155518B1 (ru)
JP (1) JPS60209557A (ru)
AT (1) ATE45945T1 (ru)
AU (1) AU567797B2 (ru)
CA (1) CA1236116A (ru)
CS (2) CS250682B2 (ru)
DD (2) DD234860A1 (ru)
DE (2) DE3410380A1 (ru)
DK (1) DK124585A (ru)
ES (1) ES541424A0 (ru)
FI (1) FI83636C (ru)
GR (1) GR850496B (ru)
HU (1) HU193596B (ru)
IL (1) IL74383A (ru)
NO (1) NO161254C (ru)
PL (2) PL143883B1 (ru)
PT (1) PT80135B (ru)
RO (2) RO91353B (ru)
SU (2) SU1333235A3 (ru)
YU (2) YU45707B (ru)
ZA (1) ZA852086B (ru)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT388099B (de) * 1986-11-26 1989-04-25 Chemie Holding Ag Verfahren zur hestellung von festen arzneiformen von (3-(3-acetyl-4-(3-tert. butylamino-2-hydroxypropoxy)-phenyl)-1,1-diethylharnstoff)- hydrochlorid

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3636209A1 (de) * 1986-10-24 1988-04-28 Lentia Gmbh Verfahren zur herstellung eines bindemittelfreien tablettierfaehigen celiprololhydrochlorid-granulates
US4931557A (en) * 1988-10-17 1990-06-05 Eli Lilly And Company Method of resolving cis 3-amino-4-(2-furyl)vinyl)-1-methoxycarbonylmethyl-azetidin-2-one and di-p-toluoyl-tartaric acid salts thereof
DE59003337D1 (de) * 1989-10-16 1993-12-09 Danubia Petrochem Polymere Pressling mit retardierter Wirkstofffreisetzung.
DE3935736A1 (de) * 1989-10-27 1991-05-02 Chemie Linz Deutschland Pressling mit retardierter wirkstofffreisetzung
US5227526A (en) * 1992-06-16 1993-07-13 Mallinckrodt Specialty Chemicals Company Resolution of 3-dimethylamino-2-methylpropiophenone (3-DAMP)
CN101239937B (zh) * 2007-02-07 2010-05-19 上海雅本化学有限公司 一种光学活性r-(-)-1-苄氧羰基-3-氨基吡咯烷及其盐酸盐的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU170678B (ru) * 1973-12-20 1977-08-28
AT334385B (de) * 1973-12-20 1976-01-10 Chemie Linz Ag Verfahren zur herstellung von neuen phenoxypropylaminderivaten und deren salzen
HU170677B (ru) * 1973-12-21 1977-08-28
US4470965A (en) * 1982-10-27 1984-09-11 Usv Pharmaceutical Corporation Celiprolol for the treatment of glaucoma

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT388099B (de) * 1986-11-26 1989-04-25 Chemie Holding Ag Verfahren zur hestellung von festen arzneiformen von (3-(3-acetyl-4-(3-tert. butylamino-2-hydroxypropoxy)-phenyl)-1,1-diethylharnstoff)- hydrochlorid

Also Published As

Publication number Publication date
ATE45945T1 (de) 1989-09-15
HU193596B (en) 1987-11-30
DK124585D0 (da) 1985-03-20
ZA852086B (en) 1985-11-27
JPS60209557A (ja) 1985-10-22
YU44485A (en) 1987-06-30
PL143883B1 (en) 1988-03-31
ES8603390A1 (es) 1985-12-16
YU44385A (en) 1987-06-30
RO91353B (ro) 1987-05-01
FI850860A0 (fi) 1985-03-04
EP0155518A2 (de) 1985-09-25
DD234860A1 (de) 1986-04-16
PT80135A (de) 1985-04-01
CA1236116A (en) 1988-05-03
AU567797B2 (en) 1987-12-03
EP0155518A3 (en) 1986-06-25
EP0155518B1 (de) 1989-08-30
YU45246B (en) 1992-05-28
NO161254C (no) 1989-07-26
NO850834L (no) 1985-09-23
FI83636B (fi) 1991-04-30
RO91352A (ro) 1987-04-30
GR850496B (ru) 1985-03-15
RO91352B (ro) 1987-05-02
IL74383A0 (en) 1985-05-31
NO161254B (no) 1989-04-17
SU1333235A3 (ru) 1987-08-23
FI83636C (fi) 1991-08-12
CS250682B2 (en) 1987-05-14
DE3572656D1 (en) 1989-10-05
DE3410380A1 (de) 1985-10-10
SU1309908A3 (ru) 1987-05-07
HUT37392A (en) 1985-12-28
AU3972285A (en) 1985-09-26
PL252463A1 (en) 1985-11-19
YU45707B (sh) 1992-07-20
FI850860L (fi) 1985-09-22
IL74383A (en) 1988-09-30
CS250683B2 (en) 1987-05-14
ES541424A0 (es) 1985-12-16
DK124585A (da) 1985-09-22
PL252462A1 (en) 1985-11-19
PT80135B (pt) 1987-10-20
RO91353A (ro) 1987-04-30

Similar Documents

Publication Publication Date Title
DE1493856B2 (de) 1-aryloxy-3-(n-alkylamino)-2-propanole, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische mittel
DE2106209A1 (de) Phenoxyhydroxypropylamine, Ver fahren zu deren Herstellung und deren Verwendung
DE2059618B2 (de) m-Halogen- a -i-butylaminoproiophenone und deren Salze, Herstellungsverfahren und pharmazeutische Zubereitung
DE2615406A1 (de) Beta-adrenergische rezeptoren-blocker
DE1967162C3 (de) 5-Methoxytetralon-(1)-derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
DE2305092C2 (ru)
DE2006978C3 (de) N- [l-(3-Trifluonnetnyl-phenyl)-propyl-(2)] -glycinderivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DD232489A1 (de) Verfahren zur herstellung von s(-)-3-(3-acetyl-4-(3-tert. butylamino-2-hydroxypropoxy)-phenyl)-1,1-diaethylharnstoff
DE1568277A1 (de) Verfahren zur Herstellung von neuen,optisch aktiven Phenylisopylamin-Derivaten
EP0155903B1 (de) Indolophenanthridine, ihre Herstellung und Verwendung
EP0030380A1 (de) 2,3-Indoldionderivate, Verfahren zu ihrer Herstellung, Zwischenprodukte, Arzneimittel enthaltend solche 2,3-Indoldionderivate und ihre pharmazeutische Verwendung
DE2611089A1 (de) Thiazolinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneipraeparate
EP0038936B1 (de) Neue 1-Aryloxy-3-alkylamino-2-propanole und Verfahren zu ihrer Herstellung
AT380232B (de) Verfahren zur herstellung von neuen s(-)-3-(3-acetyl-4-(3-tert. butylamino-2hydroxypropoxy)-phenyl)-1,1-diaethylharnstoff und dessen pharmazeutisch vertraeglichen saeureadditionssalzen
EP0225543A1 (de) Basisch substituierte Phenylacetaldehyde, ihre Herstellung und diese enthaltende Arzneimittel
CH643250A5 (de) (3-alkylamino-2-hydroxypropoxy)-furan-2-carbonsaeureanilide.
EP0029117B1 (de) 10-Bromsandwicin und 10-Bromisosandwicin sowie deren Säureadditionssalze mit pharmakoloyisch annehmbaren Säuren, Verfahren zu deren Herstellung und deren Verwendung
DE1593782B2 (de) 1-nitrilophenoxy- 2- hydroxy -3- tert.butylaminopropane, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
EP0035734B1 (de) Neue 1-(Acylamino-aryloxy-)2-hydroxy-3-alkinyl-aminopropane und Verfahren zu ihrer Herstellung
DE1950351C3 (de) l-(2-Cyano-5-methylphenoxy)-2-hydroxy-3-aIkylaminopropane, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
EP0086256B1 (de) 1-(2,4-Dichlorphenoxy)-3-(3,4-dimethoxy-Beta-phenethylamino)-2-propanol, Verfahren zu seiner Herstellung und dieses enthaltende pharmazeutische Zusammensetzungen
EP0035733B1 (de) Neue 1-(Acylamino-aryloxy-)2-hydroxy-3-alkinyl-aminopropane und Verfahren zu ihrer Herstellung
EP0014996B1 (de) Heterocyclische spiroverknüpfte Amidine, ihre Stereoisomeren und optischen Isomeren, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE2148552A1 (de) Verfahren zur Herstellung neuer heterocyclischer Verbindungen
EP0014433B1 (de) Neues links-drehendes, basisches Derivat des 9,10-Aethanoanthracens, Verfahren zu dessen Herstellung und dieses enthaltende pharmazeutische Präparate

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee